retatrutide causing diarrhea More data on dropped today at the ADA conference!! Reta is an investigational -not FDA approved yet- once-weekly medication that simultaneously activates the GIP, GLP-1, and glucagon receptors In the Phase Retatrutide Constipation: Causes, Timeline &

At 48 weeks, mean percentage changes in body weight from baseline were approximately: In the 12 mg arm, roughly 100% of participants achieved at least 5% body-weight loss, about 83% reached 15% loss, around 63% achieved 20% loss, and approximately 26% crossed the 25% threshold

As a novel method for identifying compounds that promote the release of the physiological agonist GLP-1, we have developed and optimized a GLP-1 secretion assay

Lisa 82lbs I feel great every day

Yamagishi S, Matsui T

Decreased NAD + levels in white and brown adipose tissues were associated with impaired heat production and energy metabolism in brown adipose tissue [80]